about
Endometrial cell counts in recurrent miscarriage: a comparison of counting methodsCapillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnosticsQuantitative image analysis of immunohistochemical stains using a CMYK color model.Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.p53 immunohistochemical expression in Barrett's esophagus before and after endoscopic ablation by argon plasma coagulation.Immunohistochemistry as an important tool in biomarkers detection and clinical practice.Dietary fructose causes tubulointerstitial injury in the normal rat kidneyThe clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer.Robust automated tumour segmentation on histological and immunohistochemical tissue images.When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry--the red, brown, and blue technique.Napsin A as a marker of clear cell ovarian carcinoma.Significance of human epidermal growth factor receptor 2 expression in colorectal cancer.Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a reviewImproving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysisTechnical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining.Estimation of immunohistochemical expression of VEGF in ductal carcinomas of the breast.Subcellular localization of immunohistochemical signals: knowledge of the ultrastructural or biologic features of the antigens helps predict the signal localization and proper interpretation of immunostains.Study of C-MYC amplification and expression in Iranian gastric cancer samples using CISH and IHC methods.Spatially Resolved Quantification of Chromatin Condensation through Differential Local Rheology in Cell Nuclei Fluorescence Lifetime ImagingDifferences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade IISampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.Multiplex Gene Expression Profiling of 16 Target Genes in Neoplastic and Non-Neoplastic Canine Mammary Tissues Using Branched-DNA Assay.Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancerRole of activins and inducible nitric oxide in the pathogenesis of ectopic pregnancy in patients with or without Chlamydia trachomatis infection.PATMA: parser of archival tissue microarrayMolecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study.Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.Fatal pyogranulomatous myocarditis in 10 Boxer puppies.Analysis of protein biomarkers in human clinical tumor samples: critical aspects to success from tissue acquisition to analysis.Role of oestrogen receptors in bladder cancer development.Automated measurement of MIB-1 positive area as an alternative to counting in follicular lymphoma.Quantitative phase imaging for medical diagnosis.A quantum dot-based microfluidic multi-window platform for quantifying the biomarkers of breast cancer cells.Evaluation of the Image-Pro Plus 4.5 software for automatic counting of labeled nuclei by PCNA immunohistochemistry.Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.Validation of various adaptive threshold methods of segmentation applied to follicular lymphoma digital images stained with 3,3'-Diaminobenzidine&Haematoxylin.Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays.
P2860
Q28364768-3BE4DDAE-9451-4238-AD44-305FF907DDA7Q28396457-82DEA98F-BF16-4FF5-9869-858638E736CCQ30479054-BBD2B65C-29E0-471E-B93F-BE776541A2A2Q30482618-C84C3F67-4250-4A70-ABA2-D813EB23D59EQ33216362-09219683-78C9-436E-A509-80F9C2D80B22Q33704442-086A1398-32FD-465D-AE7A-C066BECACF25Q33727809-2FA7ECF7-6B7F-4AA3-A384-8FE52983DB07Q33793170-FDE55F5C-E242-4536-9F0A-8FFD861360EAQ33840806-8B5070FF-215E-4EFD-B4E9-6CF96F477FF6Q34377983-9EEFD996-EFEE-448D-8A26-107FD1C13FE4Q34493304-515371F0-4F3C-4502-9341-1DDFCDA1389DQ34585338-DD3F00FC-B69E-46FE-ABD5-0EF4049734BAQ34659526-4BA425E1-6873-4CED-A3F0-F978A9E23A2FQ34991886-12A78632-BD04-49A5-9471-F1CEB0E2D6EBQ35587786-DDABE662-F8AF-4398-BFF7-91526D9145E0Q35681760-59092F28-ED89-4424-BA80-D71E2712DCBAQ35861253-38CDC679-AA7C-44A8-95C5-4BFF8F4EE8B2Q35884433-C34AE7EA-3AB9-4A58-9BB3-D895DE57C1B0Q35893743-7E05BBA7-F2F7-45DC-B45E-6B3C96DA838FQ35996897-463B3D69-2DFC-46FD-BA34-51F3D282C209Q36571442-CCCB3C95-6B37-4580-BBF7-CB80F8C93E58Q36595210-9FB090FB-511A-44CB-8676-027C63A505D4Q36827857-794D44DD-53B8-4BB3-BD5B-E33A6AED98DAQ37147224-7EC1970B-C740-4206-AD53-6ED559131F36Q37286664-028952F6-65E9-48CD-8848-5383BBF2B39DQ37297137-5466934F-A74E-40D2-8469-52A05D01B4ACQ37374663-C6A78262-DCF5-44C6-9013-5386CB68F815Q37470608-E522B3D2-7E83-4FDE-A4CF-5540F6BF0468Q37585385-A717E993-F098-49E6-ABED-8B32DE1746EEQ37686215-83FE641A-AB08-40C9-A15F-63D909FD37A8Q37837144-0110731C-CF1C-4208-A8CD-3AC080CE20E3Q37862749-7C4A7C42-6930-4623-B6EB-438A4D1A7633Q38099200-47F3EED7-E03A-4FAA-BCFD-ED27E356F467Q38404173-E04E9E36-B829-494D-9621-ED8DA5217598Q38931370-138685AE-F5A7-4E53-92D4-6D436A8425E3Q39018268-A9F819FF-346B-43F5-93FB-A0C48B9F0A44Q39692152-FDC458E2-8288-493F-81A8-C51E193656BCQ39847963-AB791DD5-277F-4481-A0F5-48801FBC85ACQ40100911-00731CC2-7D9B-403A-9986-88DD1F0DF12CQ40886552-2B1E477C-BD1D-40CA-A9F3-146314E9A3F5
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Interpretation and quantification of immunostains.
@ast
Interpretation and quantification of immunostains.
@en
Interpretation and quantification of immunostains.
@nl
type
label
Interpretation and quantification of immunostains.
@ast
Interpretation and quantification of immunostains.
@en
Interpretation and quantification of immunostains.
@nl
prefLabel
Interpretation and quantification of immunostains.
@ast
Interpretation and quantification of immunostains.
@en
Interpretation and quantification of immunostains.
@nl
P2093
P1476
Interpretation and quantification of immunostains.
@en
P2093
P304
P356
10.1097/00000478-200109000-00013
P407
P577
2001-09-01T00:00:00Z